RUBICON (Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation) is a “Network of Excellence” funded by the Framework Programme 6 of the European Commission over a five years period (January 2006 – December 2010). It is coordinated by Professor Maria Masucci, Karolinska Institutet, Stockholm, Sweden.
Scientists from the Max Planck Institute of Biochemistry discovered a novel cellular response towards persistent DNA damage: After being recognized... » more
The Nobel Prize in Chemistry 2004 was awarded to Aaron Ciechanover, Avram Hershko and Irwin Rose "for the discovery of ubiquitin-mediated protein d... » more
The European Molecular Biology Organization (EMBO) announced on November 4 the names of 17 young scientists who have been selected for the 2009 "EM... » more
The mysterious paradox of a carcinogenic poison which also acts as a cancer treatment has been unravelled by Ron Hay’s group in a recent paper publ... » more
The pharmaceutical company Pepscan Systems B.V. is operational since 1999. Pepscan has 25 employees including 11 technicians, and 10 PhD’s.
The c... » more
The group focuses on the analysis of two signaling pathways : NF-kappaB and Notch. More specifically, ex vivo approaches based on biochemical and g... » more
Structure/function relations of proteins involved in cell cycle, transmembrane signal transduction and the maintenance of DNA-integrity studied by... » more
BIE R&D programs are directed towards the development of reagents and assays facilitating investigation of ubiquitin and ubiquitin-like protein (Ub... » more
Our major aim is to elucidate the molecular mechanisms that determine the Growth Hormone (GH) sensitivity of cells. Cells of the human body contain... » more
The department of proteomics and signal transduction, led by Prof. Matthias Mann, was established in July 2005 and is currently comprised of 30 peo... » more
